Deutsche Biotech Innovativ AG Stock Deutsche Boerse AG
Equities
DBI
DE000A0Z25L1
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.05 EUR | -.--% | -.--% | -.--% |
Sales 2021 | - | Sales 2022 | - | Capitalization | 25.39M 27.23M |
---|---|---|---|---|---|
Net income 2021 | - 0 | Net income 2022 | - 0 | EV / Sales 2021 | - |
Net cash position 2021 | 18.92K 20.3K | Net cash position 2022 | 8.08K 8.66K | EV / Sales 2022 | - |
P/E ratio 2021 |
-371
x | P/E ratio 2022 |
-107
x | Employees | 1 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99% |
Managers | Title | Age | Since |
---|---|---|---|
Bernd Wegener
CEO | Chief Executive Officer | 76 | 08-12-31 |
Metod Miklus
COO | Chief Operating Officer | 65 | 19-10-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernd Wegener
CEO | Chief Executive Officer | 76 | 08-12-31 |
Metod Miklus
COO | Chief Operating Officer | 65 | 19-10-06 |
Renke Lührs
CHM | Chairman | 64 | 11-02-14 |
1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.84B | |
+46.40% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- DBI Stock
- DBI Stock